Clinical trials
Recruiting Obesity trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 6 |
| Amgen | 2 |
| AstraZeneca | 2 |
| Hoffmann-La Roche | 2 |
| Novo Nordisk A/S | 2 |
| Seoul National University Hospital | 2 |
| Daewoong Pharmaceutical Co. LTD. | 1 |
| Korea University Anam Hospital | 1 |
| NeuroBiogen Co., Ltd | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 21 |
| Overweight | 15 |
| Diabetes Mellitus, Type 2 | 6 |
| Diabetes Mellitus | 3 |
| Heart Failure | 2 |
| Atherosclerosis | 1 |
| Body Weight | 1 |
| Endocrine System Diseases | 1 |
| Glucose Metabolism Disorders | 1 |
| Metabolic Diseases | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.